This announcement is a separate document:
クリングルファーマ：HGF（肝細胞増殖因子）の特発性肺線維症への応用研究に関する金沢大学との共同研究開始のお知らせ
Kringle Pharma: Announcements of individual stocks: Joint research with Kanazawa University has begun on the application research of HGF (hepatocyte growth factor) for idiopathic pulmonary fibrosis.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.